Diclofenac Sodium And Misoprostol
Product Images NDC 42367-110

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium And Misoprostol (NDC 42367-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eagle Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – 50 mg Bottle Label (Dic06 0002 01)

This is a prescription medication with the name Diclofenac Sodium and Misoprostol Delayed-Release Tablets. Each bottle of this medicine contains 60 tablets. Each of these tablets comprises 50 mg of Diclofenac Sodium and 0.2 mg of Misoprostol. It is suggested to read the prescribing information before taking this medication. The medication must be stored in a dry place in the container provided, which is child-resistant. The manufacturer of the medicine is Cipla Ltd., which is based in India and it is distributed by Eagle Pharmaceuticals in Woodcliff Lake, NJ.*

FDA Label Image

Principal Display Panel – 75 mg Bottle Label (Dic06 0002 02)

This is a drug description for Diclofenac Sodium and Misoprostol Delayed-Release Tablets, which contains 50 mg of diclofenac sodium and 0.2 mg of misoprostol in each of the 90 tablets. It's an Rx-Only medication and manufactured by Cipla Ltd. The recommended storage temperature is 20° to 25°C (68° to 77°F), and it must be kept out of children's reach. The pharmacist should dispense it with the attached patient leaflet and medication guide. For further information about dosage and use, the accompanying prescribing information should be consulted.*

FDA Label Image

Principal Display Panel – 75 mg Bottle Label (Dic06 0002 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.